Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa. The Company is ...

The Mumbai-headquartered pharma company report a 11% increase in net profit for three months ended December 2024, rising to ...

Quarterly Net Profit at Rs. 232.88 crore in December 2024 up 10.88% from Rs. 210.03 crore in December 2023. EBITDA stands at ...

Quarterly Net Profit at Rs. 252.45 crore in December 2024 up 14.67% from Rs. 220.15 crore in December 2023. EBITDA stands at ...

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the ...

The artwork at Ajanta is considered a mastepiece of ancient Indian art, showcasing vibrant colours and detailed description of daily life, religious rituals, and nature. Located in the state of ...

The scam involving the embezzlement of Rs 97 crore at the Ajanta Bank came to light around one and a half years ago. The police arrested the employees and the board of directors of the bank.

The main industry in which Ajanta Pharma Ltd operates is Pharmaceuticals - Indian - Formulations. Auditor/Auditors for Ajanta Pharma Ltd is/are B S R & Co LLP. In the main management, Mannalal B ...

Ajanta Pharma with 12.3% year-on-year growth ... were among other outperformers in the listed space. Among MNCs Sanofi India with 12.2% growth also stood out and was among significant outperformers.

Article Kolkata: Airport metro’s 135-m long ‘box-pushing’ tunnel to be India’s longest Jan 29, 2025India has embarked on its longest 'box-pushing' tunneling project beneath the Kolkata ...

Ajanta Pharma Ltd (BOM:532331) reports robust financial performance with strategic expansions, despite hurdles in the Africa market.